Different profile and distribution of antigen specific T cells induced by intranasal and intrarectal immunization with rotavirus 2/6-VLP with and without LT-R192G

Vaccine

Volumn 31, Issue 15, 2013, Pages 1924-1930

  Alkadah, Abdelkarim ^a   Thiam, Fatou ^a   Mounier, Morgane ^a   Charpilienne, Annie ^b   Poncet, Didier ^b   Kohli, Evelyne ^a   Basset, Christelle ^a  

^a UNIVERSITÉ DE BOURGOGNE   (France)

^b CNRS   (France)

Author keywords

Distribution; Intranasal; Intrarectal; LT R192G; Rotavirus; T cell

Indexed keywords

ADJUVANT; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 4; ROTAVIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CERVICAL LYMPH NODE; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; IMMUNOSTIMULATION; INTERFERON INDUCTION; LYMPHOCYTE MIGRATION; LYMPHOID TISSUE; MESENTERY LYMPH NODE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; ROTAVIRUS; SPLEEN; T LYMPHOCYTE SUBPOPULATION;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRANASAL; ADMINISTRATION, RECTAL; ANIMALS; ANTIGENS, VIRAL; B-LYMPHOCYTES; BACTERIAL TOXINS; CELL MOVEMENT; CROSS-PRIMING; ENTEROTOXINS; ESCHERICHIA COLI PROTEINS; FEMALE; IMMUNITY, MUCOSAL; INTERLEUKINS; LYMPHOID TISSUE; MICE; MICE, INBRED BALB C; ROTAVIRUS; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; T-LYMPHOCYTES; VACCINATION; VACCINES, VIRUS-LIKE PARTICLE;

EID: 84875250908     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.02.019     Document Type: Article

References (27)

1. Neutra M.R., Kozlowski P.A. Mucosal vaccines: the promise and the challenge. Nat Rev Immunol 2006, 6(February (2)):148-158.
2. Nardelli-Haefliger D., Romero P., Jichlinski P. What is the influence of vaccination's routes on the regression of tumors located at mucosal sites?. Oncoimmunology 2012, 1(March (2)):242-243.
3. Holmgren J., Czerkinsky C. Mucosal immunity and vaccines. Nat Med 2005, 11(April (4 Suppl.)):S45-S53.
4. Kunkel E.J., Butcher E.C. Plasma-cell homing. Nat Rev Immunol 2003, 3(October (10)):822-829.
5. O'Neal C.M., Crawford S.E., Estes M.K., Conner M.E. Rotavirus virus-like particles administered mucosally induce protective immunity. J Virol 1997, 71(November (11)):8707-8717.
6. O'Neal C.M., Clements J.D., Estes M.K., Conner M.E. Rotavirus 2/6 virus-like particles administered intranasally with cholera toxin, Escherichia coli heat-labile toxin (LT), and LT-R192G induce protection from rotavirus challenge. J Virol 1998, 72(April (4)):3390-3393.
7. Parez N., Fourgeux C., Mohamed A., Dubuquoy C., Pillot M., Dehee A., et al. Rectal immunization with rotavirus virus-like particles induces systemic and mucosal humoral immune responses and protects mice against rotavirus infection. J Virol 2006, 80(February (4)):1752-1761.
8. Agnello D., Herve C.A., Lavaux A., Darniot M., Guillon P., Charpilienne A., et al. Intrarectal immunization with rotavirus 2/6 virus-like particles induces an antirotavirus immune response localized in the intestinal mucosa and protects against rotavirus infection in mice. J Virol 2006, 80(April (8)):3823-3832.
9. Ogier A., Franco M.A., Charpilienne A., Cohen J., Pothier P., Kohli E. Distribution and phenotype of murine rotavirus-specific B cells induced by intranasal immunization with 2/6 virus-like particles. Eur J Immunol 2005, 35(July (7)):2122-2130.
10. Di Martino C., Basset C., Ogier A., Charpilienne A., Poncet D., Kohli E. Distribution and phenotype of rotavirus-specific B cells induced during the antigen-driven primary response to 2/6 virus-like particles administered by the intrarectal and the intranasal routes. J Leukoc Biol 2007, 82(October (4)):821-828.
11. Fromantin C., Jamot B., Cohen J., Piroth L., Pothier P., Kohli E. Rotavirus 2/6 virus-like particles administered intranasally in mice, with or without the mucosal adjuvants cholera toxin and Escherichia coli heat-labile toxin, induce a Th1/Th2-like immune response. J Virol 2001, 75(November (22)):11010-11016.
12. Ciabattini A., Pettini E., Fiorino F., Prota G., Pozzi G., Medaglini D. Distribution of primed T cells and antigen-loaded antigen presenting cells following intranasal immunization in mice. PLoS ONE 2011, 6(4):e19346.
13. Thiam F., Martino C.D., Bon F., Charpilienne A., Cachia C., Poncet D., et al. Unexpected modulation of recall B and T cell responses after immunization with rotavirus-like particles in the presence of LT-R192G. Toxins (Basel) 2010, 2(August (8)):2007-2027.
14. Charpilienne A., Nejmeddine M., Berois M., Parez N., Neumann E., Hewat E., et al. Individual rotavirus-like particles containing 120 molecules of fluorescent protein are visible in living cells. J Biol Chem 2001, 276(August (31)):29361-29367.
15. Dickinson B.L., Clements J.D. Dissociation of Escherichia coli heat-labile enterotoxin adjuvanticity from ADP-ribosyltransferase activity. Infect Immun 1995, 63(May (5)):1617-1623.
16. Cua D.J., Tato C.M. Innate IL-17-producing cells: the sentinels of the immune system. Nat Rev Immunol 2010, 10(July (7)):479-489.
17. Fromantin C., Piroth L., Petitpas I., Pothier P., Kohli E. Oral delivery of homologous and heterologous strains of rotavirus to BALB/c mice induces the same profile of cytokine production by spleen cells. Virology 1998, 244(May (2)):252-260.
18. Giannasca P.J., Giannasca K.T., Falk P., Gordon J.I., Neutra M.R. Regional differences in glycoconjugates of intestinal M cells in mice: potential targets for mucosal vaccines. Am J Physiol 1994, 267(December (6 Pt 1)):G1108-G1121.
19. Meza-Sanchez D., Perez-Montesinos G., Sanchez-Garcia J., Moreno J., Bonifaz L.C. Intradermal immunization in the ear with cholera toxin and its non-toxic beta subunit promotes efficient Th1 and Th17 differentiation dependent on migrating DCs. Eur J Immunol 2011, 41(October (10)):2894-2904.
20. Saraiva M., O'Garra A. The regulation of IL-10 production by immune cells. Nat Rev Immunol 2010, 10(March (3)):170-181.
21. Smiley K.L., McNeal M.M., Basu M., Choi A.H., Clements J.D., Ward R.L. Association of gamma interferon and interleukin-17 production in intestinal CD4+ T cells with protection against rotavirus shedding in mice intranasally immunized with VP6 and the adjuvant LT(R192G). J Virol 2007, 81(April (8)):3740-3748.
22. McNeal M.M., Basu M., Bean J.A., Clements J.D., Lycke N.Y., Ramne A., et al. Intrarectal immunization of mice with VP6 and either LT(R192G) or CTA1-DD as adjuvant protects against fecal rotavirus shedding after EDIM challenge. Vaccine 2007, 25(August (33)):6224-6231.
23. Basset C., Thiam F., Martino C.D., Holton J., Clements J.D., Kohli E. Cholera-like enterotoxins and Regulatory T cells. Toxins (Basel) 2010, 2(July (7)):1774-1795.
24. Ciabattini A., Pettini E., Arsenijevic S., Pozzi G., Medaglini D. Intranasal immunization with vaccine vector Streptococcus gordonii elicits primed CD4+ and CD8+ T cells in the genital and intestinal tracts. Vaccine 2010, 28(February (5)):1226-1233.
25. Qimron U., Paul L., Bar-Haim E., Bloushtain N., Eisenbach L., Staats H.F., et al. Non-replicating mucosal and systemic vaccines: quantitative and qualitative differences in the Ag-specific CD8(+) T cell population in different tissues. Vaccine 2004, 22(March (11-12)):1390-1394.
26. Masopust D., Vezys V., Usherwood E.J., Cauley L.S., Olson S., Marzo A.L., et al. Activated primary and memory CD8 T cells migrate to nonlymphoid tissues regardless of site of activation or tissue of origin. J Immunol 2004, 172(April (8)):4875-4882.
27. Thiam F, Solanas S, Charpilienne A, Poncet D, Kohli E, Basset C. B subunits of cholera toxin and thermolabile enterotoxin of E.coli have similar adjuvant effect as whole molecules on RV 2/6-VLP specific antibody responses after IR immunization, but induce a different T cell profile. Submitted for publication.